For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Younger Group | Participants between the ages of 25-40 ZOSTAVAX: shingles vaccine, one dose | None | None | 0 | 33 | 3 | 33 | View |
| Older Group | Participants between the ages of 60-79 ZOSTAVAX: shingles vaccine, one dose | None | None | 2 | 44 | 13 | 44 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Local Injection site reactions | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Bruise at blood draw site | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Cold symptoms | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |